Evidence map›Paper›PMID 12445331›Full record

ArticleBMC infectious diseases2002

Anti-HIV-1 activity of anionic polymers: a comparative study of candidate microbicides.

A Robert Neurath, Nathan Strick, Yun-Yao Li

Open access · goldAbstract readComparative Study
In one paragraph

Article in BMC infectious diseases, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 90 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. A review of polymers as multifunctional excipients in drug dosage form technology.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2016
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. A perspective on progress and gaps in HIV prevention science.AIDS research and human retroviruses · 2012
    Article
  16. Article
  17. Amphipathic properties of HIV-1 gp41 fusion inhibitors.Current topics in medicinal chemistry · 2011
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

A Robert NeurathBiochemical Virology Laboratory, The Lindsley F, Kimball Research Institute of the New York Blood Center, New York, NY 10021, USA. arneurath@worldnet.att.net
Nathan Strick
Yun-Yao Li
New York Blood Center · US

Funding

SAFETY AND EFFICACY OF CAP IN VIVOP01HD041761 · NICHD · NEW YORK BLOOD CENTER · PI NEURATH, A ROBERT ROBERT · 2001 to 2004
$4.2M
NICHD NIH HHS P01 HD041761NICHD NIH HHS P01 HD41761
6 · The paper itself

Abstract

backgroundCellulose acetate phthalate (CAP) in soluble form blocks coreceptor binding sites on the virus envelope glycoprotein gp120 and elicits gp41 six-helix bundle formation, processes involved in virus inactivation. CAP is not soluble at pH < 5.5, normal for microbicide target sites. Therefore, the interaction between insoluble micronized CAP and HIV-1 was studied. Carbomer 974P/BufferGel; carrageenan; cellulose sulfate; dextran/dextrin sulfate, poly(napthalene sulfonate) and poly(styrene-4-sulfonate) are also being considered as anti-HIV-1 microbicides, and their antiviral properties were compared with those of CAP.

methodsEnzyme linked immunosorbent assays (ELISA) were used to (1) study HIV-1 IIIB and BaL binding to micronized CAP; (2) detect virus disintegration; and (3) measure gp41 six-helix bundle formation. Cells containing integrated HIV-1 LTR linked to the beta-gal gene and expressing CD4 and coreceptors CXCR4 or CCR5 were used to measure virus infectivity.

results1) HIV-1 IIIB and BaL, respectively, effectively bound to micronized CAP. 2) The interaction between HIV-1 and micronized CAP led to: (a) gp41 six-helix bundle formation; (b) virus disintegration and shedding of envelope glycoproteins; and (c) rapid loss of infectivity. Polymers other than CAP, except Carbomer 974P, elicited gp41 six-helix bundle formation in HIV-1 IIIB but only poly(napthalene sulfonate), in addition to CAP, had this effect on HIV-1 BaL. These polymers differed with respect to their virucidal activities, the differences being more pronounced for HIV-1 BaL.

conclusionsMicronized CAP is the only candidate topical microbicide with the capacity to remove rapidly by adsorption from physiological fluids HIV-1 of both the X4 and R5 biotypes and is likely to prevent virus contact with target cells. The interaction between micronized CAP and HIV-1 leads to rapid virus inactivation. Among other anionic polymers, cellulose sulfate, BufferGel and aryl sulfonates appear most effective in this respect.

Indexed as

Acrylic ResinsAnti-HIV AgentsBlood CoagulationCarrageenanCells, CulturedCelluloseDextransDextran SulfateHIV-1HIV Envelope Protein gp41HumansMicrobial Sensitivity TestsProtein Structure, SecondarySpermatocidal AgentsAcrylic ResinsAnti-HIV AgentsBufferGelCarrageenanCellulosecellulose sulfateDextransDextran SulfateHIV Envelope Protein gp41Spermatocidal Agents

Identifiers

PMID12445331
PMCPMC139971
OpenAlexW2111621727

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.